This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2007 Jul 7;370(9581):89-93.

doi: 10.1016/S0140-6736(07)61053-8.

Pre-exposure prophylaxis for HIV infection: what if it works?

Lynn A Paxton¹, Tony Hope, Harold W Jaffe

Affiliations

Affiliation

¹ Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. lap5@cdc.gov

PMID: 17617276
DOI: 10.1016/S0140-6736(07)61053-8

Review

Pre-exposure prophylaxis for HIV infection: what if it works?

Lynn A Paxton et al. Lancet. 2007.

. 2007 Jul 7;370(9581):89-93.

doi: 10.1016/S0140-6736(07)61053-8.

Authors

Lynn A Paxton¹, Tony Hope, Harold W Jaffe

Affiliation

¹ Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. lap5@cdc.gov

PMID: 17617276
DOI: 10.1016/S0140-6736(07)61053-8

No abstract available

PubMed Disclaimer

Similar articles

Tolerability of two different combinations of antiretroviral drugs including tenofovir used in occupational and nonoccupational postexposure prophylaxis for HIV.
Burty C, Prazuck T, Truchetet F, Christian B, Penalba C, Salmon-Ceron D, Yazdanpanah Y, May T, Rabaud C. Burty C, et al. AIDS Patient Care STDS. 2010 Jan;24(1):1-3. doi: 10.1089/apc.2009.0263. AIDS Patient Care STDS. 2010. PMID: 20095911 No abstract available.
New once-daily HIV combination better tolerated.
[No authors listed] [No authors listed] Expert Rev Anti Infect Ther. 2004 Dec;2(6):826. Expert Rev Anti Infect Ther. 2004. PMID: 15566325 Clinical Trial. No abstract available.
HIV transmission may be prevented by intravaginal tenofovir ring.
Parks L. Parks L. Future Med Chem. 2012 Dec;4(18):2239. Future Med Chem. 2012. PMID: 23359902 No abstract available.
Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate single tablet for HIV-1 infection treatment.
Olin JL, Spooner LM, Klibanov OM. Olin JL, et al. Ann Pharmacother. 2012 Dec;46(12):1671-7. doi: 10.1345/aph.1R468. Epub 2012 Nov 7. Ann Pharmacother. 2012. PMID: 23136357 Review.
Pharmacogenetics of tenofovir treatment.
Rodriguez-Novoa S, Labarga P, Soriano V. Rodriguez-Novoa S, et al. Pharmacogenomics. 2009 Oct;10(10):1675-85. doi: 10.2217/pgs.09.115. Pharmacogenomics. 2009. PMID: 19842939 Review.

See all similar articles

Cited by

Modeling dynamic interactions between pre-exposure prophylaxis interventions & treatment programs: predicting HIV transmission & resistance.
Supervie V, Barrett M, Kahn JS, Musuka G, Moeti TL, Busang L, Blower S. Supervie V, et al. Sci Rep. 2011;1:185. doi: 10.1038/srep00185. Epub 2011 Dec 7. Sci Rep. 2011. PMID: 22355700 Free PMC article.
Implementation science of pre-exposure prophylaxis: preparing for public use.
Underhill K, Operario D, Mimiaga MJ, Skeer MR, Mayer KH. Underhill K, et al. Curr HIV/AIDS Rep. 2010 Nov;7(4):210-9. doi: 10.1007/s11904-010-0062-4. Curr HIV/AIDS Rep. 2010. PMID: 20820971 Free PMC article. Review.
Willingness to use pre-exposure prophylaxis for HIV prevention among female sex workers: a cross-sectional study in China.
Peng B, Yang X, Zhang Y, Dai J, Liang H, Zou Y, Luo J, Peng H, Zhong X, Huang A. Peng B, et al. HIV AIDS (Auckl). 2012;4:149-58. doi: 10.2147/HIV.S33445. Epub 2012 Sep 24. HIV AIDS (Auckl). 2012. PMID: 23055781 Free PMC article.
Sexual risk trajectories among MSM in the United States: implications for pre-exposure prophylaxis delivery.
Pines HA, Gorbach PM, Weiss RE, Shoptaw S, Landovitz RJ, Javanbakht M, Ostrow DG, Stall RD, Plankey M. Pines HA, et al. J Acquir Immune Defic Syndr. 2014 Apr 15;65(5):579-86. doi: 10.1097/QAI.0000000000000101. J Acquir Immune Defic Syndr. 2014. PMID: 24378726 Free PMC article.
Optimizing content for pre-exposure prophylaxis (PrEP) counseling for men who have sex with men: Perspectives of PrEP users and high-risk PrEP naïve men.
Wade Taylor S, Mayer KH, Elsesser SM, Mimiaga MJ, O'Cleirigh C, Safren SA. Wade Taylor S, et al. AIDS Behav. 2014 May;18(5):871-9. doi: 10.1007/s10461-013-0617-7. AIDS Behav. 2014. PMID: 24077928 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information